Evolus Inc
NASDAQ:EOLS

Watchlist Manager
Evolus Inc Logo
Evolus Inc
NASDAQ:EOLS
Watchlist
Price: 6.9 USD 0.73% Market Closed
Market Cap: 447.3m USD

Wall Street
Price Targets

EOLS Price Targets Summary
Evolus Inc

Wall Street analysts forecast EOLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EOLS is 18.87 USD with a low forecast of 14.14 USD and a high forecast of 21 USD.

Lowest
Price Target
14.14 USD
105% Upside
Average
Price Target
18.87 USD
173% Upside
Highest
Price Target
21 USD
204% Upside
Evolus Inc Competitors:
Price Targets
4521
Kaken Pharmaceutical Co Ltd
11% Upside
SNT
Syntara Ltd
286% Upside
ROG
Roche Holding AG
4% Downside
ZYDUSLIFE
Zydus Lifesciences Ltd
14% Upside
SDZ
Sandoz Group AG
9% Downside
PPLPHARMA
Piramal Pharma Ltd
51% Upside
2DT
Amneal Pharmaceuticals Inc
8% Upside

Revenue
Forecast

Revenue Estimate
Evolus Inc

The compound annual growth rate of Evolus Inc's revenue for the next 4 years is 23%.

N/A
Past Growth
23%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Evolus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
21%
Average Beat

Net Income
Forecast

Net Income Estimate
Evolus Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EOLS's stock price target?
Price Target
18.87 USD

According to Wall Street analysts, the average 1-year price target for EOLS is 18.87 USD with a low forecast of 14.14 USD and a high forecast of 21 USD.

What is Evolus Inc's Revenue forecast?
Projected CAGR
23%

The compound annual growth rate of Evolus Inc's revenue for the next 4 years is 23%.

Back to Top